JMF4073
JMF4073 is a thymidylate (TMP) and cytidylate (CMP) kinases inhibitor with IC50s of 0.16 μM and 0.17 μM, respectively. JMF4073 eliminates wild-type (WT)-Bcr-Abl-transformed myeloid cells in vitro and in vivo.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 1927930-61-7
- 分子式: C18H22FN3O4S
- 分子量:395.45
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
WT-Bcr-Abl cells are highly susceptible to JMF4073 with GI50 0.67 μM as compared to 1.5 μM and 4.2 μM for T315I-Bcr-Abl-32D and untransformed 32D cells, respectively. The levels of overall tyrosine phosphorylation in these cells were unaffected by JMF4073 treatment[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C3H/HeNCrNarl mice injected with WT-Bcr-Abl-32D chronic myeloid leukemia (CML) cells[1]
-
Dosage:5 mg/kg
-
Administration:Intraperitoneal injection; daily; for 14 days
-
Result:Prolonged the survival of leukemia mice.
化学情報
-
CAS 番号 1927930-61-7
-
分子量 395.45
-
分子式 C18H22FN3O4S
-
SMILES
FC1=CC=C(SN(CC(N2CCN(C(OC(C)(C)C)=O)CC2)=O)C3=O)C3=C1
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)